The importance of maximal airway response to methacholine in the prediction of wheezing development in patients with cough-variant asthma

被引:35
作者
Koh, YY
Park, Y
Kim, CK
机构
[1] Seoul Natl Univ Hosp, Dept Pediat, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Clin Res Inst, Seoul 110744, South Korea
[3] Inje Univ, Sanggye Paik Hosp, Dept Pediat, Seoul, South Korea
关键词
airway hypersensitivity; classic asthma; cough-variant asthma; maximal airway response; wheezing;
D O I
10.1034/j.1398-9995.2002.23602.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 [免疫学];
摘要
Background: A significant proportion of patients diagnosed with cough-variant asthma eventually manifest classic asthma signs, such as wheezing and dyspnea. The aim of this study was to investigate whether the degree of airway hypersensitivity and/or the level of maximal airway response can predict the development of wheezing in subjects with cough-variant asthma. Methods: At study initiation, a high-dose methacholine inhalation test was performed to measure provocative concentration causing a 20% fall (PC20) in forced expiratory volume in 1 s (FEV1) and maximal airway response. Each person was evaluated regularly every 3 months for 4 years and also on the occasion of wheezing being perceived for the first time. Results: Of the 48 patients available in the follow-up period, 21 (Group 1) developed clinical wheezing, while 27 (Group 2) did not. There was no significant difference in PC20 levels between the two groups. The level of maximal airway response, however, was significantly higher in Group 1 than in Group 2. The score test for trend revealed a significant association between the future development of wheezing and the level of maximal airway response (P = 0.007), but not the level of methacholine PC20 (P = 0.423). Conclusions: The level of maximal airway response, rather than the degree of airway hypersensitivity, may be an important risk factor for the future development of classic asthma in patients with cough-variant asthma.
引用
收藏
页码:1165 / 1170
页数:6
相关论文
共 28 条
[1]
AIRWAY HYPERRESPONSIVENESS IN ALLERGIC RHINITIS - A RISK FACTOR FOR ASTHMA [J].
BRAMAN, SS ;
BARROWS, AA ;
DECOTIIS, BA ;
SETTIPANE, GA ;
CORRAO, WM .
CHEST, 1987, 91 (05) :671-674
[2]
STANDARDIZATION OF BRONCHIAL INHALATION CHALLENGE PROCEDURES [J].
CHAI, H ;
FARR, RS ;
FROEHLICH, LA ;
MATHISON, DA ;
MCLEAN, JA ;
ROSENTHAL, RR ;
SHEFFER, AL ;
SPECTOR, SL ;
TOWNLEY, RG .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1975, 56 (04) :323-327
[3]
CHRONIC COUGH AS THE SOLE PRESENTING MANIFESTATION OF BRONCHIAL-ASTHMA [J].
CORRAO, WM ;
BRAMAN, SS ;
IRWIN, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (12) :633-637
[4]
COUGH VARIANT ASTHMA IN CHILDREN [J].
HANNAWAY, PJ ;
HOPPER, GDK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (02) :206-208
[5]
THE ORIGIN OF AIRWAY HYPERRESPONSIVENESS [J].
HARGREAVE, FE ;
DOLOVICH, J ;
OBYRNE, PM ;
RAMSDALE, EH ;
DANIEL, EE .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1986, 78 (05) :825-832
[6]
HOLINGER LD, 1986, LARYNGOSCOPE, V96, P316
[7]
THE PRESENCE OF AIRWAY REACTIVITY BEFORE THE DEVELOPMENT OF ASTHMA [J].
HOPP, RJ ;
TOWNLEY, RG ;
BIVEN, RE ;
BEWTRA, AK ;
NAIR, NM .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (01) :2-8
[8]
THE SPECTRUM AND FREQUENCY OF CAUSES, KEY COMPONENTS OF THE DIAGNOSTIC EVALUATION, AND OUTCOME OF SPECIFIC THERAPY [J].
IRWIN, RS ;
CURLEY, FJ ;
FRENCH, CL .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (03) :640-647
[9]
MAXIMAL AIRWAY NARROWING IN A GENERAL-POPULATION [J].
JAMES, A ;
LOUGHEED, D ;
PEARCEPINTO, G ;
RYAN, G ;
MUSK, B .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (04) :895-899
[10]
A revised nomenclature for allergy -: An EAACI position statement from the EAACI nomenclature task force [J].
Johansson, SGO ;
Hourihane, JO ;
Bousquet, J ;
Bruijnzeel-Koomen, C ;
Dreborg, S ;
Haahtela, T ;
Kowalski, ML ;
Mygind, N ;
Ring, J ;
van Cauwenberge, P ;
van Hage-Hamsten, M ;
Wüthrich, B .
ALLERGY, 2001, 56 (09) :813-824